Pre-earnings options volume in TransMedics (TMDX) Group is 2.0x normal with calls leading puts 9:4. Implied volatility suggests the market is anticipating a move near 14.5%, or $13.81, after results are released. Median move over the past eight quarters is 11.6%.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMDX:
- TransMedics price target raised to $105 from $90 at Piper Sandler
- TransMedics Group’s OCS Drives Structural Transformation in Liver Transplantation with Increased DCD Liver Utilization
- TransMedics Group: Strong Buy Rating Amidst Robust DCD Market Performance and Growth Prospects
- TransMedics Group: Strong Market Position and Growth Potential Justify Buy Rating